CS1 Added to Standard of Care Therapy for Pulmonary Arterial Hypertension
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 126 participants.
Also called NCT07761572
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 126 participants
- Sponsor
- Cereno Scientific AB
- Registry
-
NCT07761572 -
2026-526523-22-00
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07761572. Randomized; quadruple masking; primary purpose treatment. Start 2026-09-15 (anticipated); primary completion 2029-02-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CS1 Added to Standard of Care Therapy for Pulmonary Arterial Hypertension
- Acronym
- EPIMODE
- Condition
- Pulmonary Arterial Hypertension
- Intervention (Drug)
- CS1
- Intervention (Drug)
- Placebo
- Lead sponsor
- Cereno Scientific AB
Record details
- Record id
cardio:ct-nct07761572- Content hash
5a711a99f23627ff5e3bb0123d19bbf29ea78261eea594b479ac9c6e386001c4